BELLICUM PHARMACEUTICALS INC (BLCM) Stock Earnings Estimates

NASDAQ:BLCM • US0794814048

0.622 USD
-0.07 (-9.72%)
At close: Jun 1, 2023
0.6288 USD
+0.01 (+1.09%)
After Hours: 6/1/2023, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
BLCM revenue by date.BLCM revenue by date.
500K
-93.00%
6.2M
1,140.00%
1.5M
-75.81%

-100.00%
200.41M
EBITDA
YoY % growth
BLCM ebitda by date.BLCM ebitda by date.
-52.61M
32.62%
-24.283M
53.84%
-26.97M
-11.07%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
BLCM ebit by date.BLCM ebit by date.
-54.08M
36.57%
-24.388M
54.90%
-26.981M
-10.63%
-16.068M
40.45%
-14.462M
10.00%
-13.015M
10.00%
-11.714M
10.00%
-7.862M
32.88%
Operating Margin
BLCM operating margin by date.BLCM operating margin by date.
-10,816.00%-393.35%-1,798.73%N/AN/AN/AN/A-3.92%
EPS
YoY % growth
BLCM eps by date.BLCM eps by date.
-7.40
69.06%
-1.12
84.86%
-0.81
27.59%
-0.50
38.37%
-0.32
36.73%
-0.22
29.03%
-0.17
22.73%
-0.09
47.06%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
-0.30
-127.54%
-0.09
60.09%
-0.04
79.70%
Revenue
Q2Q % growth

-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-4.414M
32.48%
-2.206M
69.21%
-1.104M
84.96%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
-0.26
-4.00%
-0.350.0925.03%
Q4 2022
Q2Q % growth
-0.20
-282.72%
-0.950.7578.81%
Q3 2022
Q2Q % growth
-0.23
-428.57%
-0.650.4264.77%
Q2 2022
Q2Q % growth
-0.13
40.91%
-0.700.5781.53%
Q1 2022
Q2Q % growth
-0.25
76.85%
-0.680.4363.42%
Q4 2021
Q2Q % growth
0.11
-88.78%
-0.410.52126.96%
Q3 2021
Q2Q % growth
0.07
138.89%
-1.401.47105.01%
Q2 2021
Q2Q % growth
-0.22
97.63%
-1.401.1884.26%
Q1 2021
Q2Q % growth
-1.08
-199.08%
-1.400.3222.71%
Q4 2020
Q2Q % growth
0.98 -1.082.06190.64%
Q3 2020
Q2Q % growth
-0.18 -3.213.0394.39%
Q2 2020
Q2Q % growth
-9.29 -3.40-5.89-173.51%
Q1 2020
Q2Q % growth
1.09 -2.783.87139.14%
BLCM Yearly EPS VS EstimatesBLCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
500K 500K%
Q3 2022
Q2Q % growth
1M
-80.00%
1M%
Q2 2022
Q2Q % growth

-100.00%
%
Q4 2021
Q2Q % growth
500K 500K%
Q3 2021
Q2Q % growth
5M 253.749K4.746M1,870.45%
Q2 2021
Q2Q % growth
700K 253.749K446.251K175.86%
Q1 2021
Q2Q % growth
253.749K-253.749K-100.00%
Q4 2020
Q2Q % growth
500K 253.749K246.251K97.05%
Q3 2020
Q2Q % growth
255K-255K-100.00%
Q2 2020
Q2Q % growth
919.53K-919.53K-100.00%
Q1 2020
Q2Q % growth
409.02K-409.02K-100.00%
BLCM Yearly Revenue VS EstimatesBLCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2027 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-222.22% -45% 0% 46.15%
RevenueN/A N/A N/A N/A